Salute e Benessere

Medtech Syndicate Announces Record-Breaking €10 Million Investment in 2024

The syndicate, which has grown significantly in recent years with 80 dedicated members, focuses on advancing cutting-edge medical technology startups. Of the deals that were done 7 qualified for the Employment and Investment Incentive Scheme (EIIS), highlighting the syndicate's alignment with government tax relief incentives for angel investors. The syndicate, which has grown significantly in recent years with 80 dedicated members, focuses on advancing cutting-edge medical technology startups...
PR Newswire
27/02/2025

ZEISS VISUMAX 800 with SMILE pro software receives approval in China

"With the growing interest in laser vision correction in China, the market needs innovative technology that enhances surgical outcomes, safety and efficiency to benefit both surgeons and their patients. The availability of the ZEISS VISUMAX 800 with SMILE pro software further extends our commitment to ophthalmologists and helps to solidify the future of laser vision correction across China," says Maximilian Foerst, Head of ZEISS Greater China. "With the growing interest in laser…
PR Newswire
27/02/2025

The Polycythemia Vera Market Landscape Heats Up Amid Rising Competition Among…

The total number of prevalent cases of polycythemia vera in the United States was around 182K cases in 2024. According to DelveInsight estimates, there were around 73K cases of asymptomatic polycythemia vera in the United States in 2024. The total number of prevalent cases of polycythemia vera inthe United Stateswas around 182K cases in 2024. According to DelveInsight estimates, there were around73Kcases of asymptomatic polycythemia vera inthe United Statesin 2024. ...
PR Newswire
26/02/2025

Alkermes to Participate in Upcoming Investor Conferences

Leerink Partners Global Healthcare Conference 2025Date/Time: Wednesday, March 12, 2025 at 11:20 a.m. ET (3:20 p.m. GMT) Leerink Partners Global Healthcare Conference 2025 Date/Time: Wednesday, March 12, 2025 at11:20 a.m. ET( 3:20 p.m. GMT ) The live webcasts may be accessed under the Investors tab onwww.alkermes.comand will be archived for 14 days. About Alkermes plc Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field...
PR Newswire
26/02/2025

Inventiva announces the publication in Biomedicine & Pharmacotherapy of the…

The study demonstrated that lanifibranor improved Portal Hypertension (PH) in mouse models of fibrotic PH and prehepatic non-fibrotic PHLanifibranor was observed to decrease portal pressure by improving Liver Sinusoidal Endothelial Cell (LSEC) dysfunction and fibrosis, and by directly targeting the splanchnic vasculature through its anti-angiogenetic effectsThese findings suggest that lanifibranor may be a promising therapeutic candidate that could potentially address PH-related...
Nasdaq GlobeNewswire
26/02/2025

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance…

Strategic Combination Aims to Accelerate Biomarker Identification, Enhance Drug Discovery, and Expand Precision Medicine Applications in Cancer and Beyond LOS ANGELES, Feb.26, 2025(GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced a definitive agreement to merge with BioSymetrics, an artificial intelligence (AI)-driven drug discovery and...
Nasdaq GlobeNewswire
26/02/2025

RAMSAY SANTE : Half-year results at the end of December 2024

PRESS RELEASE Paris, 26 thFebruary 2025 Half-year results at the end of December 2024Confirmed fundamentals Strengthening access to healthcare for all as a mission-driven company, Ramsay Santé, thanks to its employees and medical community, expands its pioneering role in access to care and medical innovation benefiting 12.6 million patients in France, Nordics and Italy. 95% of French Ramsay Santé facilities certified to the highest standards of quality...
Nasdaq GlobeNewswire
26/02/2025

RAMSAY SANTE :Half-year Financial Report as at end of December 2024 disposal

Paris, February 26, 2025 RAMSAY SANTE Half-year Financial Report as at end of December 2024 disposal This document is available on RAMSAY SANTE Internet site :http://www.ramsaysante.fr About Ramsay Santé :Ramsay Santé is leader in private hospitalisation and primary care in Europe. The Group has 38,000 employees and works with nearly 9,300 practitioners to treat more than 12 million patients per year in its 465 facilities and 5 countries:...
Nasdaq GlobeNewswire
26/02/2025

CRISPR Market is expected to generate a revenue of USD 12.78 Billion by 2032…

The CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Market is witnessing rapid advancements, with applications spanning gene editing, agriculture, drug discovery, and personalized medicine. With increasing investments in biotechnology and life sciences, the market is expected to experience exponential growth in the coming years. The CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Market is witnessing rapid advancements, with applications spanning gene...
PR Newswire
26/02/2025

Abzena Strengthens Executive Leadership Team with the Appointment of Taylor Boyd…

Matt Stober, CEO of Abzena said, "We are thrilled to welcome Taylor to Abzena's executive leadership team during this significant phase of growth for the company. Our focus remains on delivering unmatched value to our customers by driving innovation and forging partnerships that streamline and de-risk their path to market. Taylor's extensive expertise in corporate strategy and due diligence will be invaluable as we look to achieve this strategic vision and deliver best-in-class solutions…
PR Newswire
26/02/2025

Ventilator Market to Hit USD 4.66 Billion by 2029 with 4.7% CAGR |…

Browse in-depth TOC on "Ventilator Market" Browse in-depth TOC on "Ventilator Market" 286 - Tables 67 - Figures 291 - Pages In this report, the ventilators market has been segmented on the basis of type, age group, interface, mode, care settings and region. Based on interface, the hybrid ventilators segment accounted for the largest share during the forecast period. Hybrid ventilators command the largest share of the ventilator market as they are handy and can accept...
PR Newswire
26/02/2025

Antimicrobial Resistance Surveillance Market is expected to generate a revenue…

With the rising global burden of antimicrobial-resistant infections and the increasing implementation of surveillance programs worldwide, this market is witnessing significant investment and innovation. The report provides a comprehensive analysis of market trends, growth drivers, regulatory frameworks, and competitive landscape, empowering stakeholders to make informed strategic decisions. With the rising global burden of antimicrobial-resistant infections and the increasing implementation…
PR Newswire
26/02/2025

Renovaro Announces $15 million in Equity Committed

Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announces that it has $15 million in additional equity committed at a price per share of $1.00 and one privately placed cash warrant exercisable at $1.50 with a one year term.David Weinstein, Chief Executive Officer of Renovaro, commented, “We believe this new capital now enables the company to accelerate our focus on revolutionizing healthcare by combining advanced...
Nasdaq GlobeNewswire
26/02/2025

Philips accelerates precise imaging with unique AI technologies in MRI to…

February 26, 2025Philips integrates advanced AI algorithms into its MRI systems, featuring Dual AI-driven engines in SmartSpeed Precise [1] to enable faster scanningInnovations include the latest AI-enabled MR Workspace software to enhance patient throughput, reduce scan times, and improve image quality—leading to more accurate diagnoses, shorter wait times, and reduced backlogs for MRI scansThe latest technology is available across Philips' 1.5T and 3.0T MRI scanners [2],...
Nasdaq GlobeNewswire
26/02/2025

ECR 2025: Esaote Group presents Integrated Medical Imaging Solutions and unveils…

Esaote's AItechnology is now integrated into a variety of clinical applications: by optimizing workflows, reducing exam times and improving image quality, this technology empowers clinicians to make faster, data-driven decisions with heightened confidence. In the field ofMRI, Esaotelaunchesa new AI platform called"e-SPADES"at the ECR. This revolutionary technology,developed in collaboration with the Amsterdam University Medical Center and with AIRS Medical, can...
PR Newswire
26/02/2025

Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I…

COPENHAGEN, Denmark, Feb. 26, 2025 /PRNewswire/ -- Adcendo, a biotech company pioneering the development of first and best-in-class ADCs for cancers with a high unmet medical need, today announced that the U.S. Food & Drug Administration (FDA) has provided clearance of the IND application for a Phase I study evaluating ADCE-T02 in patients with advanced solid tumors. COPENHAGEN, Denmark , Feb. 26, 2025 /PRNewswire/ -- Adcendo, a biotech company pioneering the development of first and...
PR Newswire
26/02/2025

MoonLake Immunotherapeutics Reports Full Year 2024 Financial Results and…

Initiated the Phase 3 VELA program of the Nanobody ®sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS) and the Phase 3 IZAR program in patients with active psoriatic arthritis (PsA) following positive FDA and EMA regulatory feedback, continuing to support a potential best-in-class profile across two key indicationsInitiated three new trials in the beginning of 2025 with the Nanobody ®sonelokimab: Phase 3 VELA-TEEN trial in adolescent hidradenitis...
Nasdaq GlobeNewswire
26/02/2025

AscellaHealth Supports Rare Disease Patients and Caregivers in Observance…

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, reaffirms its commitment to supporting the300 millionindividuals worldwide affected by rare diseases. In recognition ofRare Disease Day, held annually on the last day of February, the AscellaHealth team participates in this global initiative to raise awareness about rare diseases and highlight the strength and unity within these communities. Emphasizing the need for...
Nasdaq GlobeNewswire
26/02/2025

Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration

About the Zymeworks and GSK Collaboration In April 2016, we entered into a platform technology transfer and license agreement with GSK to research, develop and commercialize up to six bispecific antibodies generated using our Azymetric™ platform. Under the terms of this agreement, we granted GSK a worldwide, royalty-bearing antibody sequence pair-specific exclusive license to research, develop and commercialize licensed products. In May 2019, this agreement was expanded to provide GSK...
Nasdaq GlobeNewswire
26/02/2025

OMO Partners With Saudi Henna Artists to Educate Women on Female Stain Removal

This absence of conversation can lead to a lack of knowledge and misinformation around how to effectively manage period stains. According to the research 70% of women have thrown away clothes or bed sheets due to period stains that could not be removed. Understanding the need for a safe and comfortable space for women to be confident enough to have open discussions and share experiences, OMO has launched an innovative education campaign to bring period care to the heart ofSaudi...
PR Newswire
26/02/2025

ERS Genomics: European Patent Office Grants CVC Portfolio Key CRISPR Patent

DUBLIN and CHESTER, England, Feb. 26, 2025 /PRNewswire/ -- ERS Genomics ('ERS'), which was established to provide broad access to the foundational CRISPR/Cas9 intellectual property developed by Prof. Emmanuelle Charpentier announced today that the European Patent Office ('EPO') has published its decision to grant patent number EP 4 289 948. The divisional patent includes broad independent claims covering single guide RNAs, modified DNA-targeting RNAs and the combination guide RNAs with Cas9…
PR Newswire
26/02/2025

RESPIREE SECURES SINGAPORE HSA CLEARANCE FOR PEDIATRIC EXPANSION OF…

WHY IT MATTERS WHY IT MATTERS "This important regulatory extension enablesSingapore'shealthcare systems, as well as other international healthcare systems, to accurately capture and utilize cardio-respiratory data in a broader pediatric population, beyond just adults. Furthermore, Respiree's software platform now streamlines workflow integration, facilitating seamless transitions of care not only within hospitals but also from hospitals to homes through our new pathway management...
PR Newswire
26/02/2025

Experienced Industry Leader Tom Arnold Appointed as Chief Executive Officer of…

Jan Keltjens, Chairman of the Board at ViCentra, said: "Tom's extensive experience in commercial strategy, his deep knowledge of the healthcare sector, and personal connection to the diabetes community make him uniquely qualified to lead ViCentra into its next phase of growth. I am pleased to welcome Tom to the ViCentra team as we position ViCentra to accelerate growth, broaden access to Kaleido and make life with diabetes more personal and simpler." Jan Keltjens, Chairman of the Board…
PR Newswire
26/02/2025

AIRS Medical to Showcase Latest MRI Breakthroughs at ECR

AIRS Medical will also highlight its global presence through a strategic partnership with Esaote, a leading provider of diagnostic imaging equipment worldwide. AIRS Medical will also highlight its global presence through a strategic partnership with Esaote, a leading provider of diagnostic imaging equipment worldwide. Meet AIRS Medical Visit AI Exhibition Hall #AI-39to meet the AIRS Medical team and experience firsthand how SwiftMR: "AI is transforming radiology, and SwiftMR is at...
PR Newswire
26/02/2025
Altri  Comunicati